InvestorsHub Logo

harlem111

03/01/11 7:23 PM

#29857 RE: interstate #29856

Thanks and I love this line in particular--"As each of the trials will be open-label, the company may, once the trials commence, be able to share details on the safety profile and response of the patients prior to the end of the trials." GLTA

diannedawn

03/02/11 3:36 PM

#29879 RE: interstate #29856

very thorough evaluation of those entities that will be the company’s partners to ensure that the trials have the highest likelihood of success


I'm not quite sure what factors about the clinical partners could help ensure their success?

Any medical people out there with insight on what those factors could be?

Nice to see them firmly state there is no delay ....

:)
Thanks for sharing interstate!